[ad_1] Eli Lilly is tightening its grip on the lucrative...
Abbott Labs shares surge on earnings and a big sign of confidence in the business
[ad_1] Shares of Abbott Laboratories jumped Wednesday after the diversified...
Jim Cramer’s week ahead: Earnings from Goldman Sachs, Johnson & Johnson and Netflix
[ad_1] CNBC's Jim Cramer on Friday told investors which market-moving...
Hard-hit Apple bounces back with the market, and an analyst is divided on our drug stocks
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer...
Cramer’s week ahead: Banks kick off critical earnings season
[ad_1] After President Donald Trump's new tariffs crushed global stocks...
We’re exiting our position in a health-care stock to raise some cash
[ad_1] Shortly after the opening bell, we will be exiting...
Jim Cramer says the selling in this portfolio stock is excessive — and why bond yields matter
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer...
Don’t overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers
[ad_1] The drug stock is higher over the past month...
Costco’s not-so secret weapon: How Kirkland Signature is driving growth and profits
[ad_1] A weaker environment for consumer spending is playing right...
We’re buying more shares of 2 stocks as the broader market sinks further
[ad_1] We're making our first trades of the week. We...